Bausch & Lomb set out Wednesday to assuage investor fears as retailers began pulling one of its contact lens solutions from shelves amid a U.S. government investigation over whether it is linked to a serious eye infection.
CNN
Money
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
RightEye’s Parkinson’s Diagnostic Gets Breakthrough Status
Physicians “rely on a variety of neurological examinations to confirm the clinical diagnosis,” RightEye said.
FDA Approves Global Blood Therapeutics’ Sickle Cell Disease Treatment
The FDA handed the medication breakthrough therapy, fast track, orphan drug, and rare pediatric disease designations, as well as priority review.
FDAnews Device Daily Bulletin
BAUSCH & LOMB GIRDS FOR SOLUTION-RELATED LOSSES
April 14, 2006
